📋 Tender Overview
19 June 2026 Science and Technology Secretary Liz Kendall has appointed Anna King as a non-executive member to the UK Research and Innovation (UKRI) Board from September 2026.
Anna brings extensive board-level, commercial, financial, and innovation leadership experience across the public and private sectors.
UKRI Chair Sir Andrew Mackenzie said:
Annas expertise and insight in governance, investment, innovation, commercial strategy, and cross-sector partnership working will be an enormous asset to the UKRI Board as the organisation delivers its mission to advance knowledge, improve lives and drive growth.
About Anna King
She is currently Commercial Director at the Health Innovation Network.
As Executive Lead for DigitalHealth.London, she has played a pivotal role in accelerating innovation, supporting high-growth health technology companies, and strengthening collaboration across the NHS, industry, investors, and academia.
A Chartered Accountant and experienced Non-Executive Director, Anna currently serves as Chair of the Audit, Risk and Compliance Committee at Lewisham and Greenwich NHS Trust.
She holds advisory board roles, including with the NHS Innovation Accelerator and the NHS Alliances Q Initiative.
Over the course of her career, Anna has worked across:
corporate finance
private equity
healthcare innovation
public sector transformation
This includes roles at PwC and leadership positions supporting large-scale innovation and economic growth programmes.
She has been instrumental in developing nationally-recognised initiatives such as DigitalHealth.London and Accelerating FemTech in partnership with Innovate UK.